Pseudohypoparathyroidism
|
Estimated prevalence of 0.3 to 1.1 /100,000. Heterogeneous group of diseases caused by insensitivity to parathyroid hormone, leading to renal and/or bone abnormalities.
From a genetic point of view, several types are identified:
The GNAS gene encodes the stimulating alpha subunit (Gs), an intracellular G protein that stimulates the production of cAMP in response to certain physiological stimuli.
Clinical presentation:
In childhood, hypocalcemia can lead to crises of tetany, muscle cramps or seizures. Later: muscle weakness, bone pain.
Comparative table:
Name |
phenotype |
PTH rate |
vit D |
CA |
phosphates |
Erythrocyte gs |
hypoparathyroidism |
normal |
low |
low |
low |
high |
normal |
pseudo hypopara 1A |
dysplasia |
high |
low |
low |
high |
diminished |
pseudo hypopara 1B |
normal |
high |
low |
low |
high |
normal |
pseudo hypopara 1C |
dysplasia |
high |
low |
low |
high |
normal |
pseudohypopara 2 |
normal |
high |
low |
low |
high |
normal |
pseudopseudo hypoparathyroidism |
dysplasia |
normal |
normal |
normal |
normal |
normal |
Treatment: supplements of calcium and vitamin D and phosphate chelators by mouth.
Anesthetic implications:
check calcemia, avoid hyperventilation. Make sure that there are no other associated endocrine abnormalities (types Ia and Ic)
References :
- Kahloul N, Chaari W, Boughamoura L, Charfeddine L, Khammeri S, Amri F.
Un syndrome de Fahr révélateur d’une pseudohypoparathyroïdie.
Arch Pédiatr 2009 ; 16 :444-8.
Updated: May 2022